{"id":"89c3141d-c2b8-52d5-b00c-fe89ee9c6c6e","stable_key":"10629adf-a816-5b7b-82db-a76bfbb946f2:bg-training-reaches-the-marrow","predicate":"causes","statement":"Administration of beta-glucan as a prototypical trained-immunity-inducing agonist to mice induced expansion of progenitors of the myeloid lineage which was associated with elevated signalling by innate immune mediators such as IL-1 beta and granulocyte-macrophage colony-stimulating factor and with adaptations in glucose metabolism and cholesterol biosynthesis, and the trained-immunity-related increase in myelopoiesis resulted in a beneficial response to secondary LPS challenge and protection from chemotherapy-induced myelosuppression in mice.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"99d58d5f-261f-5463-b35b-6f3f0676b73c","mechanism_event_label":"The change is not only in the cells circulating now; it reaches the factory that makes the next ones.","subject":{"id":"1e73e18e-eca0-56b0-b3de-a850ea95344f","slug":"beta-glucan","display_name":"Beta-glucan","entity_type_key":"chemical_species"},"object":{"id":"10813237-006a-525d-9e97-cc8dc1a05497","slug":"myeloid-progenitor-expansion","display_name":"Expansion of myeloid-lineage progenitors in the bone marrow","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"99d58d5f-261f-5463-b35b-6f3f0676b73c","stable_key":"10629adf-a816-5b7b-82db-a76bfbb946f2:bg-training-reaches-the-marrow-event","event_type":"biochemical_relationship","label":"The change is not only in the cells circulating now; it reaches the factory that makes the next ones.","description":"Administration of beta-glucan as a prototypical trained-immunity-inducing agonist to mice induced expansion of progenitors of the myeloid lineage which was associated with elevated signalling by innate immune mediators such as IL-1 beta and granulocyte-macrophage colony-stimulating factor and with adaptations in glucose metabolism and cholesterol biosynthesis, and the trained-immunity-related increase in myelopoiesis resulted in a beneficial response to secondary LPS challenge and protection from chemotherapy-induced myelosuppression in mice.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"e9fa1ab4-707e-5ff9-9d60-11f503b54c58","slug":"il1b","display_name":"Interleukin-1 beta / IL1B","entity_type_key":"cytokine"},"role":"signalling_mediator","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"09bab956-7807-5660-a044-e91bdc3a6380","slug":"csf2","display_name":"Granulocyte-macrophage colony-stimulating factor / GM-CSF","entity_type_key":"cytokine"},"role":"signalling_mediator","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"a5bc919c-20f4-57ef-b186-dab7c7addbbd","slug":"glycolysis","display_name":"Glycolysis","entity_type_key":"cellular_process"},"role":"adapted_pathway","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"8d038691-634e-5ef7-afdd-f70337ae0b67","slug":"cholesterol-synthesis-pathway","display_name":"The cholesterol synthesis pathway","entity_type_key":"cellular_process"},"role":"adapted_pathway","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"27ca600e-302d-5741-9c17-9a9a8660b67b","slug":"chemotherapy-myelosuppression","display_name":"Chemotherapy-induced myelosuppression","entity_type_key":"cellular_process"},"role":"protected_outcome","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"f20d18e3-2923-5c01-9851-40e9f3a65b0c","slug":"secondary-infection-resistance","display_name":"Resistance to a secondary infectious challenge","entity_type_key":"cellular_process"},"role":"measured_outcome","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""},{"entity":{"id":"1e73e18e-eca0-56b0-b3de-a850ea95344f","slug":"beta-glucan","display_name":"Beta-glucan","entity_type_key":"chemical_species"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":6,"notes":""},{"entity":{"id":"10813237-006a-525d-9e97-cc8dc1a05497","slug":"myeloid-progenitor-expansion","display_name":"Expansion of myeloid-lineage progenitors in the bone marrow","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":7,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/glucan-research/29328910.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"d81bb64ee275e9aef7d9a59be186b5082906172a79c6f0d943832662f226b0d5\", \"start_char\": 0, \"end_char\": 1023, \"text_sha256\": \"d81bb64ee275e9aef7d9a59be186b5082906172a79c6f0d943832662f226b0d5\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Administration of beta-glucan to mice with assessment of haematopoietic stem and progenitor cells and two challenge models","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Beta-glucan as a prototypical trained-immunity-inducing agonist, followed by secondary LPS challenge or chemotherapy","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A mouse study with parenteral administration. It shows progenitors are modulated; it does not show that a swallowed glucan reaches human marrow.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair.","comparator":null,"unit":null,"notes":"","entity":{"slug":"beta-glucan","display_name":"Beta-glucan","entity_type_key":"chemical_species"}},{"dimension":"organism","value_text":"Mouse","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The change is not only in the cells circulating now; it reaches the factory that makes the next ones.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[bg-p29328910] Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. (2018). https://pubmed.ncbi.nlm.nih.gov/29328910/ DOI: 10.1016/j.cell.2017.11.034","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Bone marrow","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"77a41a1f-757f-5983-8bcf-e8eefcd971fd","evidence_kind":"source_excerpt","locator":"Lines 476-487","start_line":476,"end_line":487,"excerpt":"### bg-training-reaches-the-marrow\nAdministration of beta-glucan as a prototypical trained-immunity-inducing agonist to mice induced expansion of progenitors of the myeloid lineage which was associated with elevated signalling by innate immune mediators such as IL-1 beta and granulocyte-macrophage colony-stimulating factor and with adaptations in glucose metabolism and cholesterol biosynthesis, and the trained-immunity-related increase in myelopoiesis resulted in a beneficial response to secondary LPS challenge and protection from chemotherapy-induced myelosuppression in mice.\nCondition category: normal\nnutrient_topic: Beta-glucan research collection; topical membership is not evidence of a direct clinical effect, and each preparation is recorded as its own entity with no family link joining any pair.\nplain_language: The change is not only in the cells circulating now; it reaches the factory that makes the next ones.\norganism: Mouse\ntissue_or_cell_type: Bone marrow\nexperimental_model: Administration of beta-glucan to mice with assessment of haematopoietic stem and progenitor cells and two challenge models\nlimitations: A mouse study with parenteral administration. It shows progenitors are modulated; it does not show that a swallowed glucan reaches human marrow.\nexposure: Beta-glucan as a prototypical trained-immunity-inducing agonist, followed by secondary LPS challenge or chemotherapy\nevidence_span: {\"source_cache\": \"artifacts/glucan-research/29328910.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"d81bb64ee275e9aef7d9a59be186b5082906172a79c6f0d943832662f226b0d5\", \"start_char\": 0, \"end_char\": 1023, \"text_sha256\": \"d81bb64ee275e9aef7d9a59be186b5082906172a79c6f0d943832662f226b0d5\"}\n[bg-p29328910] Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. (2018). https://pubmed.ncbi.nlm.nih.gov/29328910/ DOI: 10.1016/j.cell.2017.11.034","model_system":"Administration of beta-glucan to mice with assessment of haematopoietic stem and progenitor cells and two challenge models","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [bg-p29328910] Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity. (2018). https://pubmed.ncbi.nlm.nih.gov/29328910/ DOI: 10.1016/j.cell.2017.11.034","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"74dc223d-8289-57bf-a731-d220fa017c1e","stable_key":"import-10629adf-a816-5b7b-82db-a76bfbb946f2","title":"Beta-glucan: a structural family rather than an agent, what decides whether a bound glucan actually signals, the complement route that a cereal and a yeast preparation share, and the unequal human evidence behind each (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"7c62f2d2f8d99b650e6dc26a505b0f053ae1c8bdb38099d4dfc0771f65287461","revision_id":"a53bb794-0a4b-525d-9cf7-22b46a5403b0","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}